AdaptHealth Corp. (AHCO)
NASDAQ: AHCO · Real-Time Price · USD
9.42
-0.09 (-0.95%)
At close: Sep 8, 2025, 4:00 PM
9.60
+0.18 (1.91%)
After-hours: Sep 8, 2025, 6:12 PM EDT
AdaptHealth Stock Forecast
Stock Price Forecast
The 5 analysts that cover AdaptHealth stock have a consensus rating of "Strong Buy" and an average price target of $13.4, which forecasts a 42.25% increase in the stock price over the next year. The lowest target is $11 and the highest is $16.
Price Target: $13.4 (+42.25%)
Analyst Consensus: Strong Buy
* Price targets were last updated on May 12, 2025.
Analyst Ratings
The average analyst rating for AdaptHealth stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Securities | Truist Securities | Strong Buy Maintains $14 → $13 | Strong Buy | Maintains | $14 → $13 | +38.00% | May 12, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $14 → $13 | Buy | Maintains | $14 → $13 | +38.00% | May 8, 2025 |
| Baird | Baird | Buy Maintains $14 → $16 | Buy | Maintains | $14 → $16 | +69.85% | Feb 27, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $13 → $14 | Strong Buy | Maintains | $13 → $14 | +48.62% | Feb 26, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $11 → $14 | Buy | Maintains | $11 → $14 | +48.62% | Feb 26, 2025 |
Financial Forecast
Revenue This Year
3.29B
from 3.26B
Increased by 0.98%
Revenue Next Year
3.51B
from 3.29B
Increased by 6.53%
EPS This Year
0.96
from 0.61
Increased by 57.74%
EPS Next Year
1.14
from 0.96
Increased by 18.86%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 3.4B | 3.8B | ||
| Avg | 3.3B | 3.5B | ||
| Low | 3.2B | 3.3B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 4.7% | 14.6% | ||
| Avg | 1.0% | 6.5% | ||
| Low | -3.3% | -0.5% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 1.20 | 1.39 | |||
| Avg | 0.96 | 1.14 | |||
| Low | 0.65 | 0.85 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 96.2% | 44.0% | |||
| Avg | 57.7% | 18.9% | |||
| Low | 6.0% | -11.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.